CompletedNot Applicable

Systematic Evaluation of Continuous Glucose Monitoring Data

Switzerland384 participantsStarted 2018-04-01

Plain-language summary

This study retrospectively evaluates continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) data and pursues two main objectives: First, the investigators analyze if glucose values are better controlled in the days directly before a consultation at our tertiary referral centre (so called "white coat adherence"). Second, the investigators use the collected CGM and FGM data to develop a hypoglycemia prediction model.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diabetes mellitus * CGM and/or FGM available for at least 50% of the time in last 4 weeks before consultation * Written informed general consent for the retrospective analysis of data Exclusion Criteria: * Pregnancy

What they're measuring

Change of time in target glucose range day 0-3 compared to day 4-28 and day 0-7 compared to day 8-28 prior to consultation (for Substudy A)

Timeframe: 01.01.2013 - 31.07.2018; outcome assessed at study end

Hypoglycemia prediction (for Substudy B)

Timeframe: 01.01.2013 - 31.07.2018; outcome assessed at study end

Trial details

NCT IDNCT03545178

SponsorInsel Gruppe AG, University Hospital Bern

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-07-19

View on ClinicalTrials.gov More Diabetes Mellitus trials